Novel Regimens Identified in Mice for Treatment of Latent Tuberculosis Infection in Contacts of Patients with Multidrug-Resistant Tuberculosis

Por Lanoix, Jean-Philippe, Betoudji, Fabrice, Nuermberger, Eric
Publicado em 2014

Correction for Lanoix et al., Novel Regimens Identified in Mice for Treatment of Latent Tuberculosis Infection in Contacts of Patients with Multidrug-Resistant Tuberculosis

Por Lanoix, Jean-Philippe, Betoudji, Fabrice, Nuermberger, Eric
Publicado no Antimicrob Agents Chemother (2015)

Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis

Por Lanoix, Jean-Philippe, Betoudji, Fabrice, Nuermberger, Eric
Publicado no Antimicrob Agents Chemother (2016)

Autoluminescent Mycobacterium tuberculosis for Rapid, Real-Time, Non-Invasive Assessment of Drug and Vaccine Efficacy

Por Zhang, Tianyu, Li, Si-Yang, Nuermberger, Eric L.
Publicado em 2012

Toward an Evidence-Based Nonclinical Road Map for Evaluating the Efficacy of New Tuberculosis (TB) Drug Regimens: Proceedings of a Critical Path to TB Drug Regimens-National Instit...

Por Nuermberger, Eric, Sizemore, Christine, Romero, Klaus, Hanna, Debra
Publicado no Antimicrob Agents Chemother (2016)

Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis

Por Lanoix, Jean-Philippe, Lenaerts, Anne J., Nuermberger, Eric L.
Publicado no Dis Model Mech (2015)

Current Development and Future Prospects in Chemotherapy of Tuberculosis

Por Nuermberger, Eric L., Spigelman, Melvin K., Yew, Wing Wai
Publicado no Respirology (2010)

Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?

Por Lanoix, Jean-Philippe, Chaisson, Richard E., Nuermberger, Eric L.
Publicado no Clin Infect Dis (2016)

Pipeline of drugs for related diseases: tuberculosis

Por Dooley, Kelly E., Nuermberger, Eric L., Diacon, Andreas H.
Publicado no Curr Opin HIV AIDS (2013)

Enhanced Bactericidal Activity of Rifampin and/or Pyrazinamide When Combined with PA-824 in a Murine Model of Tuberculosis

Por Tasneen, Rokeya, Tyagi, Sandeep, Williams, Kathy, Grosset, Jacques, Nuermberger, Eric
Publicado em 2008

In Vivo Validation of the Mutant Selection Window Hypothesis with Moxifloxacin in a Murine Model of Tuberculosis

Por Almeida, Deepak, Nuermberger, Eric, Tyagi, Sandeep, Bishai, William R., Grosset, Jacques
Publicado em 2007

Rapid Assessment of Antibacterial Activity against Mycobacterium ulcerans by Using Recombinant Luminescent Strains

Por Zhang, Tianyu, Bishai, William R., Grosset, Jacques H., Nuermberger, Eric L.
Publicado em 2010

Bactericidal Activity of Increasing Daily and Weekly Doses of Moxifloxacin in Murine Tuberculosis

Por Yoshimatsu, Tetsuyuki, Nuermberger, Eric, Tyagi, Sandeep, Chaisson, Richard, Bishai, William, Grosset, Jacques
Publicado em 2002

BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse

Por Converse, Paul J., Almeida, Deepak V., Nuermberger, Eric L., Grosset, Jacques H.
Publicado em 2011

Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Por Converse, Paul J, Nuermberger, Eric L, Almeida, Deepak V, Grosset, Jacques H
Publicado em 2011

Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks

Por Srivastava, Shashikant, Deshpande, Devyani, Pasipanodya, Jotam, Nuermberger, Eric, Swaminathan, Soumya, Gumbo, Tawanda
Publicado no Clin Infect Dis (2016)

Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?

Por Rosenthal, Ian M., Zhang, Ming, Almeida, Deepak, Grosset, Jacques H., Nuermberger, Eric L.
Publicado em 2008

Short-Course Therapy with Daily Rifapentine in a Murine Model of Latent Tuberculosis Infection

Por Zhang, Tianyu, Zhang, Ming, Rosenthal, Ian M., Grosset, Jacques H., Nuermberger, Eric L.
Publicado em 2009

Short-Course Chemotherapy with TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis Infection

Por Zhang, Tianyu, Li, Si-Yang, Williams, Kathy N., Andries, Koen, Nuermberger, Eric L.
Publicado em 2011

Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo

Por Deshpande, Devyani, Srivastava, Shashikant, Nuermberger, Eric, Pasipanodya, Jotam G., Swaminathan, Soumya, Gumbo, Tawanda
Publicado no Clin Infect Dis (2016)